The National MS Society has released a new report detailing the lived experiences of people with MS and highlighting unmet ...

USA, in the 1970s, Stephen Hauser met Andrea, a critically ill young patient with multiple sclerosis (MS) and acute severe ...

If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...

"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...

MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...

BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday morning — making the step forward toward finding a cure for multiple ...

Irisin, a hormone released during exercise, appears to directly shield neurons from damage in a mouse model of multiple ...

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

Multiple sclerosis goes undetected because its early symptoms mimic common problems. It is highly under-diagnosed in India.

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

Patients suffering from Multiple Sclerosis (MS) have raised urgent concerns over the exorbitant cost of and lack of access to modern treatment for the chronic neurological disease in ...